![]() |
Leukemia |
Free Subscription
1 Acta Haematol |
Retrieve available abstracts of this week’s articles:
HTML format |
Single Articles |
AMEDEO Leukemia is free of charge.
Disseminated Mucormycosis and T-Cell-Depleted Allogeneic Stem Cell
Transplantation: An Unusual Case Study.
Acta Haematol. 2025;148:362-368.
PubMed
Abstract available
KRAS may facilitate transformation of chronic lymphocytic leukemia to histiocytic
sarcoma with indeterminate dendritic cell features.
Am J Clin Pathol. 2025 May 26:aqaf041. doi: 10.1093.
PubMed
Abstract available
Detection of TP53 mutations by immunohistochemistry in acute myeloid leukemia
varies with interpreter expertise and mutation status.
Am J Clin Pathol. 2025 May 25:aqaf047. doi: 10.1093.
PubMed
Abstract available
CPX-351 (Vyxeos) in Acute Myeloid Leukemia: Time to Move on?
Am J Hematol. 2025 May 29. doi: 10.1002/ajh.27730.
PubMed
Abstract available
The expression patterns and prognostic significance of PD-1 and TIM-3 on T cells
and the differentiated subsets in acute myeloid leukemia.
Ann Hematol. 2025 May 27. doi: 10.1007/s00277-025-06418.
PubMed
Abstract available
Subclonal emergence of polycythemia vera, chronic myelomonocytic leukemia, and
chronic myeloid leukemia.
Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06417.
PubMed
Abstract available
Matching-adjusted indirect comparison of CPX- 351 in secondary Acute Myeloid
Leukemia between the registrative trial and a real-life study.
Ann Hematol. 2025 May 24. doi: 10.1007/s00277-025-06381.
PubMed
Abstract available
Precision medicine for high-risk gene fusions in pediatric AML: a focus on KMT2A,
NUP98, and GLIS2 rearrangements.
Blood. 2025;145:2574-2586.
PubMed
Abstract available
Venetoclax and decitabine vs intensive chemotherapy as induction for young
patients with newly diagnosed AML.
Blood. 2025;145:2645-2655.
PubMed
Abstract available
RBM15-MKL1 fusion protein promotes leukemia via m6A methylation and WNT pathway
activation.
Blood. 2025 May 28:blood.2024027712. doi: 10.1182/blood.2024027712.
PubMed
Abstract available
HNRNPC and m6A RNA methylation control oncogenic transcription and metabolism in
T-cell leukemia.
Blood. 2025 Apr 15:blood.2024026848. doi: 10.1182/blood.2024026848.
PubMed
Abstract available
Differentiation-dependent EBF1 Activity Determines CD22 Transcription and
Leukemia Sensitivity to Inotuzumab Ozogamicin.
Blood. 2025 May 28:blood.2024028215. doi: 10.1182/blood.2024028215.
PubMed
Abstract available
Prognostic significance of cytogenetic risk score in patients with secondary
acute myeloid leukemia undergoing allogeneic stem cell transplantation from
HLA-matched unrelated donors: a study from the ALWP /EBMT.
Bone Marrow Transplant. 2025 May 29. doi: 10.1038/s41409-025-02620.
PubMed
Abstract available
Improved outcomes over time in patients aged >/=60 years undergoing allogeneic
hematopoietic cell transplantation for acute lymphoblastic leukemia in first
complete remission: a large study by the EBMT acute leukemia working party.
Bone Marrow Transplant. 2025 May 28. doi: 10.1038/s41409-025-02630.
PubMed
Abstract available
Clinical outcomes of a new local CD19 CAR-T cell therapy for patients with
relapsed or refractory acute lymphoblastic leukemia and non-Hodgkin lymphoma in
Malaysia.
Bone Marrow Transplant. 2025 May 27. doi: 10.1038/s41409-025-02629.
PubMed
Effective leukemia-to-granulocyte induction by a cocktail of RUNX1, SPI1 and
CEBPE.
Cancer Lett. 2025;626:217820.
PubMed
Impact of Conditioning Intensity on Survival in Adult Patients (< 65 Years) With
Acute Myeloid Leukemia Receiving Antithymocyte Globulin and Post-Transplantation
Cyclophosphamide Based GVHD Prophylaxis.
Eur J Haematol. 2025 May 28. doi: 10.1111/ejh.14438.
PubMed
Abstract available
Asciminib in patients with newly diagnosed chronic myeloid leukemia: results from
the Japanese subgroup of ASC4FIRST.
Int J Hematol. 2025 May 26. doi: 10.1007/s12185-025-04014.
PubMed
Abstract available
Comparison of clinical outcomes between preemptive and maintenance therapy after
allogeneic hematopoietic stem cell transplantation for acute myeloid leukemia.
Int J Hematol. 2025 May 23. doi: 10.1007/s12185-025-04009.
PubMed
Abstract available
Transplantation outcomes of TP53-mutant AML and MDS: a single transplantation
center experience of 63 patients.
Int J Hematol. 2025;121:820-832.
PubMed
Abstract available
High-dose cytarabine with idarubicin consolidation for acute myeloid leukemia in
first complete remission: a randomized controlled trial.
Leukemia. 2025 May 28. doi: 10.1038/s41375-025-02655.
PubMed
Abstract available
Peripheral Blood Flow Cytometry-based Definition of Plasma Cell Leukemia.
Leukemia. 2025 May 26. doi: 10.1038/s41375-025-02653.
PubMed
Integrative analysis of epigenetic subtypes in acute myeloid Leukemia: A
multi-center study combining machine learning for prognostic and therapeutic
insights.
PLoS One. 2025;20:e0324380.
PubMed
Abstract available
Thank you for your interest in scientific medicine.